NCT05554367 2026-03-18Palbociclib and Binimetinib in RAS-Mutant Cancers, A ComboMATCH Treatment TrialNational Cancer Institute (NCI)Phase 2 Active not recruiting199 enrolled
NCT04553133 2025-08-28PF-07104091 as a Single Agent and in Combination TherapyPfizerPhase 2 Active not recruiting154 enrolled